Aerobic and Resistance Exercise in Cancer Patients: Methods and Benefits
In this presentation, Dr. Wood and Dr.
Category
Format
Credits
  • Participation
Tumor Treating Fields for Glioblastoma
Glioblastoma is a devastating disease with a survival that is measured in months.
Category
Format
Credits
  • Participation
Recent Advances on the Gut Microbiome and Cancer Therapy
The gut microbiome is responsible for regulation of many functions in humans including metabolism, immune responses and inflammation.
Category
Format
Credits
  • Participation
Novel Molecularly Targeted Therapies and Biomarkers in Advanced Colorectal Cancer
Treatment of metastatic colorectal cancer has continued to evolve over the last several years, with emerging identification of biomarkers that underlie heterogeneity of responses to new and existing therapy.
Category
Format
Credits
  • Participation
Using Biomarkers to Plan Adjuvant Therapy in Breast Cancer
Lisa Carey, MD, will discuss the anatomic and genomic variables that impact on (neo)adjuvant decision-makin
Category
Format
Credits
  • Participation
Acute Myeloid Leukemia (AML): Finally Making Progress?
Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy that affects approximately 20,000 patients each year in the United States.
Category
Format
Credits
  • Participation
GU Cancers: Best of ASCO
The Genitourinary Cancers Symposium co-sponsored by the American Society of Clinical Oncology (ASCO), American Society for Radiation Oncology (ASTRO), and Society of Urologic Oncology (SUO) provides some of th
Category
Format
Credits
  • Participation
Meeting the Unique Needs of Pediatric Oncology Patients
Children with cancer, and their clinicians, face a unique spectrum of challenges.
Category
Format
Credits
  • Participation
A New Era: Immunotherapy in Non-Small Cell Lung Cancer
This lecture will describe the rationale behind using immunotherapy in lung cancer, the current standard of care use of immunotherapy, and future directions.
Category
Format
Credits
  • Participation
Managing Lung Cancer Heterogeneity
The most common lung cancers are known to have diverse pathological features and recent research has further identified distinct diseases with genetic and cellular heterogeneity.
Category
Format
Credits
  • Participation

Pages